SEC Form 4 · accession 0000930413-18-003233
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elazar Rabbani
Officer — Chm of the Bd, CEO and Sec · Director
Period of report
Oct 29, 2018
Accepted (ET)
Oct 31, 2018 · 9:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 29, 2018 | P | 10,000 | $3.3469 | A | 1,848,668 | D |
Table II — derivative securities
No Table II lines on this filing.